Conditional Lpar1 Gene Targeting Identifies Cell Types Mediating Neuropathic Pain

doi 10.1101/2020.02.02.931212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Immunotherapy Targeting Cytokines in Neuropathic Pain

Frontiers in Pharmacology
Pharmacology
2013English

Targeting the Endogenous Cannabinoid System to Treat Neuropathic Pain

Frontiers in Pharmacology
Pharmacology
2014English

Targeting Voltage-Gated Calcium Channels for Neuropathic Pain Management

Neurotherapeutics
NeurologyPharmacology
2009English

Targeting Gene Expression to Specific Cardiovascular Cell Types in Transgenic Mice

Hypertension
Internal Medicine
1993English

Targeting Angiotensin II Type 2 Receptor Pathways to Treat Neuropathic Pain and Inflammatory Pain

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Cannabinoids Suppress Inflammatory and Neuropathic Pain by Targeting Α3 Glycine Receptors

Journal of Experimental Medicine
MedicineAllergyImmunology
2012English

Targeting nNOS Ameliorates the Severe Neuropathic Pain Due to Chronic Pancreatitis

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Characterization of Neuropathic Pain in Sickle Cell Disease

West Indian Medical Journal
Medicine
2017English

Lessons on Conditional Gene Targeting in Mouse Adipose Tissue

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy